Skip to main content

BMT APTALIS Pill - white capsule/oblong

Pill with imprint BMT APTALIS is White, Capsule/Oblong and has been identified as Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride 140 mg / 125 mg / 125 mg. It is supplied by H2-Pharma, LLC.

Bismuth subcitrate potassium/metronidazole/tetracycline is used in the treatment of Helicobacter Pylori Infection and belongs to the drug class H. pylori eradication agents. There is positive evidence of human fetal risk during pregnancy. Bismuth subcitrate potassium/metronidazole/tetracycline 140 mg / 125 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMT APTALIS

Bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride 140 mg / 125 mg / 125 mg BMT APTALIS

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride

Imprint
BMT APTALIS
Strength
140 mg / 125 mg / 125 mg
Color
White
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
H. pylori eradication agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
H2-Pharma, LLC
National Drug Code (NDC)
61269-0385

Get help with Imprint Code FAQs.

Related images for "BMT APTALIS"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.